HomeNewsBusinessBudgetINTERVIEW | Confident of listing LIC, selling BPCL, Air India in FY22, says DIPAM Secretary Tuhin Kanta Pandey

INTERVIEW | Confident of listing LIC, selling BPCL, Air India in FY22, says DIPAM Secretary Tuhin Kanta Pandey

DIPAM Secretary Tuhin Kanta Pandey told Moneycontrol that while the names of two state-owned banks and one general insurance company to be privatised are yet to be decided, just announcing that PSBs are up for privatisation was a big statement of intent in itself.

February 03, 2021 / 09:00 IST
Story continues below Advertisement
DIPAM Secretary Tuhin Kanta Pandey.
DIPAM Secretary Tuhin Kanta Pandey.

While the names of two public sector banks (PSBs) and one general insurance company to be privatised are yet to be decided, just announcing that state-run banks are up for privatisation was a big statement of intent in itself, Tuhin Kanta Pandey, Secretary of the Department of Investment and Public Asset Management, or DIPAM, told Moneycontrol on February 2.

In an exclusive interview a day after the Union Budget 2021-22 was presented, Pandey said the coming year’s divestment target of Rs 1.75 lakh crore is based mostly on privatisation plans of Bharat Petroleum Corporation Ltd (BPCL), Air India, Container Corporation of India Ltd or CONCOR, Shipping Corporation of India, Pawan Hans and others, and the planned initial public offering (IPO) of LIC Ltd. Excerpts:

Story continues below Advertisement

Q: We know that the government had big plans for privatisation in the current financial year. However, the COVID-19 pandemic derailed those plans. How confident are you of your plans in FY22 and meeting the Rs 1.75 lakh crore target?

A: If you would have looked at our FY22 target, it is slightly lower than FY21, because a lot of our focus is on realistic targets, and we also have to build credibility. We could have met our targets this year, and were on track. But there was a bad COVID year which derailed the process. We did not stop our preparations. So several of those transactions which were stuck, they have been resumed, and they will be carried forward and culminated. At the same time, this Budget has given a directional shift to the whole agenda of structural reforms. So for the first time since 2004, there's a very clear statement of intent of privatisation.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show